Cardiovascular disease continues to be the leading cause of death for both men and women in the United States. According to the Centers for Disease Control and Prevention (CDC), one of every four deaths is from heart disease. As evidence-based therapies to reduce cardiovascular events continue to emerge so has the complexity of selecting appropriate lipid-lowering therapy for patients. Health care providers can reference the 2018 American College of Cardiology and American Heart Association evidence-based recommendations for cholesterol management and atherosclerotic cardiovascular disease (ASCVD) reduction.
In this archived webinar, you will learn the latest in the use of statins and non-statins for ASCVD risk reduction, and how to identify patients who may be appropriate for treatment.
At the completion of this knowledge-based activity, participants will be able to:
- Review recent evidence in cholesterol management and atherosclerotic cardiovascular disease (ASCVD) risk reduction.
- Discuss management strategies for patients who experience statin-associated muscle symptoms.
- Identify appropriate patients who might benefit from select non-statin therapies shown to reduce ASCVD risk.
Activity type: Knowledge-based
Target Audience: Pharmacists
Learning Level: 2
The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The following archived webinar is approved for 1.0 contact hour of CPE credit (0.1 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-19-125-H01-P.
To obtain credit for completing 2018 Update on Cholesterol Management and ASCVD Risk Reduction (Home Study), watch the archived webinar, complete the assessment with a grade of 70% or better, complete the evaluation questions, and then CLAIM credit. Participants need to have a valid pharmacist.com username and password to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.
Initial release date: February 20, 2019
Expiration date: February 20, 2022
2018 Update on Cholesterol Management and ASCVD Risk Reduction (Home Study) is an archived, online educational activity for pharmacists developed by the American Pharmacists Association.
Dave L. Dixon, PharmD, FACC, FCCP, FNLA, BCPS, BCACP, CDE, CLS and APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, visit the APhA website at www.pharmacist.com/apha-disclosures.
Conflicts of interest have been resolved through content review by Helen Sairany, BA, PharmD, MBA, BCACP, Director of Content Development & Partnership at the American Pharmacists Association.
There is no fee associated with this member only activity.
*This webinar will be archived and made available as an online learning activity within 1 week after the live offering has been presented. The archived webinar (home-study version) will be available to APhA members ONLY, as a free member benefit, during the first 30 days after release. Thereafter, nonmembers can purchase the archived webinar at a cost of $129.*
Computer and internet access are required to complete this activity. Please visit our website to view the Technology System Requirements in order to have a positive learning experience.